← Open Payments lookup

NPI 1669534160: Open Payments

NPI 1669534160. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,037 in 43 payments from 9 companies in 2025. Trend: 2023 $806 · 2024 $1,250 · 2025 $1,037

Food & beverage: $862Education: $176
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.15$520
GlaxoSmithKline, LLC.17$264
Optinose US, Inc.3$90
GENZYME CORPORATION2$59
Organon LLC2$26
Novartis Pharmaceuticals Corporation1$22
AstraZeneca Pharmaceuticals LP1$20
Blueprint Medicines Corporation1$19
Amgen Inc.1$18

Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, Xhance, AYVAKIT, VTAMA, AIRSUPRA, TEZSPIRE.